Literature DB >> 10736003

Prevalence and characteristics of verotoxin-producing Escherichia coli (VTEC) in stool samples from asymptomatic human carriers working in the meat processing industry in Switzerland.

R Stephan1, S Ragettli, F Untermann.   

Abstract

A total of 5590 stool samples from healthy employees in the meat industry were screened by PCR for verotoxin-producing Escherichia coli (VTEC). The PCR product of VT-encoding genes was detected in 3. 5% of the samples. Phenotypic and genotypic traits of 47 VTEC strains isolated from asymptomatic carriers were characterized. A variety of serotypes was found; one strain belonged to the serotype O157:H7. The majority of the isolates proved to be VT2-positive. Fifty-seven percent of the verotoxin-producing strains harboured the genes for one or several additional virulence associated factors, including intimin (eae, 8.5%), the 60 MDa plasmid (42.5%), enterohaemolysin (EHEC-hlyA, 38.3%), the heat-stable enterotoxin (astA, 6.4%), a serin protease (espP, 6.4%), colicin production (col D157, 12.8%) and a secretion system II (etpD, 10.6%). None of the strains was positive for a specific enzyme with catalase-peroxidase activity (katP).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736003     DOI: 10.1046/j.1365-2672.2000.00965.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  16 in total

1.  Prevalence of shiga toxin-producing Escherichia coli in a diarrheagenic Tunisian population, and the report of isolating STEC O157:H7 in Tunis.

Authors:  Nazek Al-Gallas; Olfa Bahri; Ridha Ben Aissa
Journal:  Curr Microbiol       Date:  2006-11-17       Impact factor: 2.188

2.  Design of a seven-genome Escherichia coli microarray for comparative genomic profiling.

Authors:  Hanni Willenbrock; Anne Petersen; Camilla Sekse; Kristoffer Kiil; Yngvild Wasteson; David W Ussery
Journal:  J Bacteriol       Date:  2006-09-08       Impact factor: 3.490

3.  Prevalence of Escherichia coli O157:H7 in Children with Bloody Diarrhea Referring to Abuzar Teaching Hospital, Ahvaz, Iran.

Authors:  Azar Dokht Khosravi; Soheila Khaghani; Ahmad Farajzadeh Sheikh; Ali Ahmadzadeh; Ahmad Shamsizadeh
Journal:  J Clin Diagn Res       Date:  2016-01-01

4.  High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam.

Authors:  Oliver James Dyar; Nguyen Quynh Hoa; Nguyen V Trung; Ho D Phuc; Mattias Larsson; Nguyen T K Chuc; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2012-04-18       Impact factor: 3.090

5.  Evidences of lateral gene transfer between archaea and pathogenic bacteria.

Authors:  Habib Bokhari; Maryam Anwar; Hasan Bilal Mirza; Patrick Martin Gillevet
Journal:  Bioinformation       Date:  2011-07-06

6.  Prevalence of Verotoxin-Producing Escherichia coli (VTEC) in a survey of dairy cattle in Najaf, Iraq.

Authors:  A Al-Charrakh; A Al-Muhana
Journal:  Iran J Microbiol       Date:  2010-09

7.  Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009.

Authors:  Taru Lienemann; Eeva Salo; Ruska Rimhanen-Finne; Kai Rönnholm; Mari Taimisto; Jari J Hirvonen; Eveliina Tarkka; Markku Kuusi; Anja Siitonen
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

Review 8.  Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.

Authors:  C Mark Taylor
Journal:  Pediatr Nephrol       Date:  2008-05-21       Impact factor: 3.714

9.  Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli.

Authors:  Catalina López-Saucedo; Jorge F Cerna; Nicolas Villegas-Sepulveda; Rocío Thompson; F Raul Velazquez; Javier Torres; Phillip I Tarr; Teresa Estrada-García
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Lateral gene transfer (LGT) between Archaea and Escherichia coli is a contributor to the emergence of novel infectious disease.

Authors:  David M Faguy
Journal:  BMC Infect Dis       Date:  2003-06-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.